Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-05-03Clinical Trial Update: Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 study evaluating the combination of Flavopiridol (alvocidib) and imatinib mesylate in patients with leukemia has completed, reportin…
-
CLINICAL_TRIALS research · 2010-04-13Clinical Trial Update: Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome [Phase 3]
This entry notes a Phase 3 trial evaluating low-dose decitabine versus standard supportive care in older patients with myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Biological Therapy in Treating Patients With Myelodysplastic Syndrome [Phase 2]
A Phase 2 clinical trial evaluating a biological therapy for myelodysplastic syndromes has completed, with leukemia also listed as an associ…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating bone marrow transplantation in patients with hematologic cancers has completed. The trial covered severa…
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [Phase 2]
A Phase 2 trial evaluating the combination of chemotherapy with bone marrow or peripheral stem cell transplantation in patients with chronic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [Phase 2]
The document reports the completion of a Phase 2 trial evaluating umbilical cord blood transplantation in patients with hematologic cancers …
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation [Phase 3]
A Phase 3 trial evaluating budesonide to prevent acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation…
-
CLINICAL_TRIALS research · 2010-03-23Clinical Trial Update: Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors [Phase 1]
Phase 1 clinical trial update sponsored by Pacira Pharmaceuticals evaluating chemotherapy for children and young patients with recurrent or …
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating cyclophosphamide and/or mycophenolate mofetil with or without tacrolimus in patients undergoing donor bone…
-
CLINICAL_TRIALS trial_result · 2010-03-16Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial of a monoclonal antibody therapy for advanced cancer has been completed, evaluating patients across several hematologic and …
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 study evaluating a combination chemotherapy regimen with infusion of leukocytes in patients with hematologic cancers, which has co…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome [Phase 1]
Completed Phase 1 study evaluating safety and initial efficacy of the combination of 3-AP followed by fludarabine in patients with relapsed …
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: MS-275 in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 trial of MS-275 (entinostat) in patients with hematologic cancers, including leukemia, multiple myeloma/plasma cell neoplasms, and…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial of cyclophosphamide followed by bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-24Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma [Phase 2, Phase 3]
This clinical trial update covers Phase 2 and Phase 3 evaluation of bone marrow transplantation for patients with leukemia, myelodysplastic …
-
CLINICAL_TRIALS trial_result · 2010-02-17Clinical Trial Update: Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma [Phase 1]
A Phase 1 trial evaluating Bryostatin-1 in combination with high-dose cytarabine in patients with refractory or relapsed leukemia or lymphom…
-
CLINICAL_TRIALS research · 2010-01-28Clinical Trial Update: Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders [Phase 2]
A Phase 2 clinical trial update evaluating stem cell transplantation for hematological cancers or related disorders, listing conditions such…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder [Phase 1]
This Phase 1 trial evaluating 12-O-tetradecanoylphorbol-13-acetate in hematologic cancers and bone marrow disorders was terminated.
-
CLINICAL_TRIALS trial_result · 2009-12-31Clinical Trial Update: Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. [Phase 2]
Phase 2 clinical trial evaluating donor umbilical cord blood natural killer cells with aldesleukin and umbilical cord blood transplant in re…
-
CLINICAL_TRIALS trial_result · 2009-11-16Clinical Trial Update: Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
This update reports on a completed trial comparing piperacillin-tazobactam alone versus with a glycopeptide in neutropenic patients with hem…
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma [Phase 2]
Phase 2 trial results evaluate rasburicase as a uricolytic therapy to treat hyperuricemia in patients with leukemia or lymphoma.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors [Phase 4]
Phase 4 study comparing aprepitant plus palonosetron versus granisetron for the prevention of chemotherapy-induced nausea and vomiting in pa…
-
CLINICAL_TRIALS trial_result · 2009-09-03Clinical Trial Update: Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor umbilical cord blood transplant by intra-bone-marrow injection for hematologic cancers; trial term…
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
Phase 2 clinical trial evaluating treosulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation, focusing on saf…
-
CLINICAL_TRIALS research · 2009-07-08Clinical Trial Update: Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants
This clinical trial update describes biomarkers studied in people at risk for myelodysplastic syndromes and in healthy participants, sponsor…